IBB icon

iShares Biotechnology ETF

850 hedge funds and large institutions have $7.09B invested in iShares Biotechnology ETF in 2021 Q3 according to their latest regulatory filings, with 71 funds opening new positions, 239 increasing their positions, 292 reducing their positions, and 64 closing their positions.

Holders
850
Holders Change
-8
Holders Change %
-0.93%
% of All Funds
14.93%
Holding in Top 10
8
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-38.46%
% of All Funds
0.14%
New
71
Increased
239
Reduced
292
Closed
64
Calls
$456M
Puts
$447M
Net Calls
+$9.29M
Net Calls Change
+$21.9M
Name Market Value Shares Shares
Change
Shares
Change %
DWA
901
Delos Wealth Advisors
Texas
-711 Closed
T2I
902
Turim 21 Investimentos
Brazil
-500 Closed
PWP
903
Personal Wealth Partners
Minnesota
-497 Closed
AS
904
Altshuler Shaham
Israel
-415 Closed
JAWM
905
J. Arnold Wealth Management
Ohio
-270 Closed
RPCA
906
Running Point Capital Advisors
California
-260 Closed
FIA
907
FNY Investment Advisers
New York
-200 Closed
FFG
908
Ford Financial Group
California
-167 Closed
SB
909
Strategic Blueprint
Georgia
-150 Closed
EI
910
Ellevest Inc
New York
-41 Closed
BCA
911
Berman Capital Advisors
Georgia
-34 Closed
MAM
912
Meeder Asset Management
Ohio
-25 Closed
PI
913
PEAK6 Investments
Illinois
-5 Closed
OC
914
Oakworth Capital
Alabama
-1 Closed
Squarepoint
915
Squarepoint
New York
TSS
916
Two Sigma Securities
New York
TCWA
917
Ten Capital Wealth Advisors
Washington
PP
918
Paloma Partners
Connecticut
CA
919
Continental Advisors
Utah
Capstone Investment Advisors
920
Capstone Investment Advisors
New York
$0 3
SFA
921
Semmax Financial Advisors
North Carolina
$0 1
SA
922
SpiderRock Advisors
Delaware
COCM
923
Charter Oak Capital Management
New Hampshire
$0 3
TFS
924
TrustCore Financial Services
Tennessee
$0 2 +1 +100%